By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
October 27, 2025 2:33 PM EDT
Medical Herald
Search
  • Health Conditions
    Health ConditionsShow More
    Medtronic Launches Ankle Implant for Bladder Control
    Health Conditions
    Stewart’s Caring Place Highlights All Cancer Awareness in October
    Breast Cancer
    Michael J. Fox Reflects on Life and Health Amid Parkinson’s Struggles
    Health Conditions
    Microplastics Linked to Gut Changes: Implications for Health
    Health Conditions
    Princess Kate Urges Parents to Prioritize Real Connections
    Pregnancy & Parenting
  • Wellness & Self-Care
    Wellness & Self-CareShow More
    Discover the Health Benefits of Hazelnuts
    Healthy Living
    How the Government Shutdown Affects Health Insurance Costs
    Wellness & Self-Care
    NYC Sues Tech Giants Over Youth Mental Health Crisis
    Mental Health
    Understanding Deep and REM Sleep: Essential for Recovery
    Wellness & Self-Care
    Osceola Students Champion Mental Health in ‘Build-A-Bill’ Contest
    Mental Health
  • Nutrition & Fitness
    Nutrition & FitnessShow More
    Calcium Loaf: A Depression-Era Recipe for Today’s Food Challenges
    Healthy Recipes
    Effective Full-Body Workout Enhances Testosterone and Muscle
    Fitness
    Impact of the Carnivore Diet on Your Health
    Diet & Nutrition
    Boost Your Mobility: Charley Hull’s Top 3 Workout Routines
    Fitness
    California Takes Bold Step to Improve School Nutrition
    Diet & Nutrition
  • Innovation
    InnovationShow More
    How ALV-J Virus Bypasses Immune Defense Using miR-155
    Innovation
    Nursing Homes’ Use of Painkillers and Antidepressants Raises Risks
    Drugs & Medications
    FDA to Decide on Biohaven’s Ataxia Treatment in November
    Drugs & Medications
    Study Links Bumper Stickers to Aggressive Driving Behavior
    Innovation
    China Achieves First Pig-to-Human Liver Transplant
    Innovation
  • News
    NewsShow More
    Harry and Meghan Shine at World Mental Health Day Gala in NYC
    News
    Emergency Medicaid for Undocumented Immigrants: A Costly Misconception
    News
    Poll Shows Public Skepticism Toward Trump’s Health Claims
    News
    NYC’s Food Insecurity Crisis: Students Need More Than Education
    News
    Concerns Rise Over Research Funding Cuts Amid Stroke Patient Crisis
    News
Font ResizerAa
Medical HeraldMedical Herald
  • Health Conditions
  • Wellness & Self-Care
  • Nutrition & Fitness
  • Innovation
  • News
Search
  • Health Conditions
  • Wellness & Self-Care
  • Nutrition & Fitness
  • Innovation
  • News
Follow US
Copyright © 2025, Medical Herald. All Rights Reserved.
Home » Innovation » How ALV-J Virus Bypasses Immune Defense Using miR-155

How ALV-J Virus Bypasses Immune Defense Using miR-155

By Samuel Lee
Published: October 27, 2025
Share

Avian leukosis virus subgroup J (ALV-J) is a significant oncogenic retrovirus that leads to severe health issues in poultry, including immunosuppression and the formation of tumors like myelocytomas. While previous research has established that ALV-J can evade innate immunity, the specific mechanisms behind this evasion have remained elusive. Recent studies reveal that ALV-J enhances the expression of microRNA-155 (miR-155), a key player in the suppression of immune responses, ultimately facilitating viral replication.

Contents
  • Author Summary
  • Introduction
  • miRNA and Immune Evasion
  • Experimental Findings
  • Conclusions
  • Data Availability
  • Funding
  • Keywords

In our research, we identified that the p27 viral protein from ALV-J significantly reduces the activity of a cellular protein called DEAD-box helicase 3X (DDX3X). This action diminishes DDX3X expression and promotes the maturation of the MIR155 host gene into active miR-155. The mature miR-155 then targets two crucial proteins, tumor necrosis factor receptor-associated factor 3 (TRAF3) and signal transducer and activator of transcription 1 (STAT1), both of which are essential for the initiation of type I interferon (IFN-I) responses. By silencing TRAF3 or STAT1, researchers found that ALV-J replication, which would normally be inhibited by miR-155, is restored.

This discovery marks a notable advance in understanding the immune evasion tactics employed by retroviruses such as ALV-J, shedding light on their complex pathogenesis.

Author Summary

ALV-J is known for causing considerable economic repercussions in the poultry industry due to its ability to disrupt immune function and induce tumors. Our study illuminates how ALV-J manipulates the host microRNA, miR-155, to escape the body’s antiviral responses. By compromising the function of DDX3X, ALV-J can increase miR-155 levels. This rise in miR-155, in turn, blocks the action of TRAF3 and STAT1—critical regulators in the immune response—thereby suppressing the production of interferons that would typically hinder viral replication. Through this mechanism, the virus effectively lowers its chances of being eradicated by the host immune system.

Introduction

ALV-J represents a rapidly evolving oncogenic retrovirus that poses significant health threats to poultry by inducing immunosuppression and neoplastic diseases. These conditions lead to reduced growth rates, susceptibility to infections, and overall productivity losses in affected flocks. The virus can spread both horizontally and vertically, with vertical transmission linked to more pronounced pathogenic effects, especially during early stages of a chicken’s life.

The ability of ALV-J to evade the host immune response is crucial for its infection and persistence. This evasion is facilitated by the virus’s unique strategies that exploit host factors, such as miRNAs, to counteract antiviral defenses. However, the underlying mechanisms by which ALV-J escapes immune detection remain less well-defined.

miRNA and Immune Evasion

miRNAs are small, non-coding RNAs that regulate gene expression. They play significant roles in both innate and adaptive immune responses, making them intriguing targets for viral immune evasion strategies. For instance, studies have shown that several oncogenic viruses effectively manipulate host miRNA functions to promote their own longevity and pathogenicity.

Our research highlights that while ALV-J induces various miRNAs, including miR-200b-3p, miR-34b-5p, and miR-23b, miR-155 is particularly prominent in the virus’s ability to escape immune responses. Elevated levels of miR-155 were found to block critical components of the host’s antiviral response, particularly affecting IFN production.

Experimental Findings

To explore how ALV-J influences miR-155 levels and subsequent immune suppression, CEFs (chicken embryo fibroblasts) were infected with ALV-J, revealing that infection led to a substantial increase in miR-155 levels. Notably, DDX3X was identified as a significant interacting partner that p27 protein of ALV-J targets to promote miR-155 maturation.

Following this, functional assays demonstrated that increasing miR-155 exerted a negative impact on ALV-J-induced IFN-β production, highlighting the intricate mechanism by which ALV-J manipulates the host immune response. Importantly, DDX3X overexpression was found to reverse the miR-155 induced decrease in TRAF3 and STAT1, confirming that these proteins are key targets for miR-155-mediated immune evasion during viral infections.

Conclusions

The findings establish a novel miR-155-dependent pathway whereby ALV-J sidesteps host immune defenses, ultimately promoting viral replication and persistence. This mechanism illustrates the complex dynamics of host-virus interactions and opens avenues for future research into potential therapeutic targets that could disrupt these viral evasion strategies.

Data Availability

All data supporting this research are provided in the manuscript and supplementary files.

Funding

This study received financial support from several sources, including the Natural Science Foundation of China and the Key Research and Development Program of Shandong Province.

Keywords

  • Avian leukosis virus subgroup J
  • miR-155
  • Innate immunity
  • TRAF3
  • STAT1
  • Viral replication

Diseases & Conditions

Share This Article
Facebook LinkedIn Email Copy Link
Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

HOT NEWS

Medtronic Launches Ankle Implant for Bladder Control

October 27, 2025

Nursing Homes’ Use of Painkillers and Antidepressants Raises Risks

Researchers warn that tramadol-antidepressant combinations heighten seizure risk in elderly patients, spotlighting over-medication in nursing…

October 27, 2025

FDA to Decide on Biohaven’s Ataxia Treatment in November

As the FDA weighs Biohaven’s SCA drug approval, patients and investors await a pivotal decision…

October 27, 2025

Calcium Loaf: A Depression-Era Recipe for Today’s Food Challenges

The Great Depression’s calcium loaf returns as a nutrient-rich, sustainable recipe using eggshell calcium and…

October 27, 2025

YOU MAY ALSO LIKE

AstraZeneca and Daiichi Sankyo Achieve Milestone in Cancer Study

AstraZeneca and Daiichi Sankyo’s Datroway achieved major success in a late-stage trial, offering new hope for patients with triple-negative breast…

October 8, 2025

Direct Reduced Iron Market Set for Steady Growth Through 2034

The global Direct Reduced Iron market is projected to reach $96.4B by 2034, fueled by sustainable steelmaking and clean energy…

October 10, 2025

AlphaMedixTM Proves Effective in Treating Neuroendocrine Tumors

Phase 2 results show AlphaMedix hit primary goals with strong responses and tolerability in GEP-NETs, underscoring 212Pb targeted alpha therapy’s…

October 16, 2025

Exploring Bidirectional Inheritance in Digital DNA Systems

A new study encodes music into DNA to simulate reverse genetic flow, offering insights into Lamarckian inheritance and artificial evolutionary…

October 16, 2025

Medical Herald is your trusted source for medical news, scientific research, health policy updates, and expert insights from around the world. 

Category

  • Health Conditions
  • Wellness & Self-Care
  • Nutrition & Fitness
  • Innovation
  • News
  • Privacy Policy
  • About Us
  • Contact

Follow US: 

  • Grow Big Agency Sites:
  • London Business Journal
Copyright © 2025, Medical Herald. All Rights Reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?